comparemela.com

Latest Breaking News On - Saurabh saha - Page 1 : comparemela.com

Centessa Begins Narcolepsy Drug Candidate ORX750 Trials

Centessa recently initiated the phase 1 clinical trial of ORX750, an orexin receptor 2 agonist in development for narcolepsy treatment.

Saurabh sahaCentessa pharmaceuticalsDrug administrationInvestigational new drugChief executive officer

Centessa Pharmaceuticals plc: Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2024

Centessa Pharmaceuticals plc: Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2024
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesCity ofKristenk sheppardTechnology platformCentessa pharmaceuticalsExchange commissionOrexin agonist programEuropean association for haemophiliaUpcoming program milestonesHemophilia programLockbody technology platformResearch development expensesDrug administrationAgonist programOngoing phase

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2024

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2024
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomCity ofKristenk sheppardUpcoming program milestonesExchange commissionEuropean association for haemophiliaHemophilia programLockbody technology platformResearch development expensesDrug administrationOrexin agonist programTechnology platformCentessa pharmaceuticalsAgonist programOngoing phase

Centessa Pharmaceuticals Announces Open IND for ORX750; Proof-of-Concept Data in Sleep-Deprived Healthy Volunteers Planned for 2H 2024

BOSTON and LONDON, April 22, 2024 Centessa Pharmaceuticals plc , a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients, today.

City ofUnited kingdomUnited statesKristenk sheppardExchange commissionCentessa pharmaceuticalsDrug administrationInvestigational new drugWakefulness testKarolinska sleepiness scaleSaurabh sahaChief executive officerAnnual reportQuarterly reportsInvestor relations

FDA OKs Phase 1 Trial of Narcolepsy Drug Candidate ORX750

Centessa has received FDA clearance to start a phase 1 trial of ORX750, aimed at narcolepsy and other sleep-wake disorders.

Saurabh sahaCentessa pharmaceuticalsDrug administrationCentessa pharmaceuticalWakefulness testKarolinska sleepiness scaleInvestigational new drug

vimarsana © 2020. All Rights Reserved.